Sindrome emolitico-uremica (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Sindrome emolitico-uremica" in Italian language version.

refsWebsite

Global rank Italian rank

41nih.gov

4^th place

9^th place

26doi.org

2^nd place

7^th place

21oadoi.org

799^th place

22^nd place

10archive.org

6^th place

8^th place

9books.google.com

3^rd place

14^th place

4medscape.com

719^th place

799^th place

3web.archive.org

1^st place

2repubblica.it

78^th place

2^nd place

1msdmanuals.com

4,047^th place

1,347^th place

1ansa.it

493^rd place

15^th place

1who.int

195^th place

342^nd place

1iss.it

low place

1,085^th place

1rcsb.org

8,838^th place

low place

1state.il.us

6,835^th place

low place

1oxfordjournals.org

1,389^th place

732^nd place

ansa.it

Batterio killer, casi sospetti in Europa - Top News - ANSA.it, su ansa.it. URL consultato il 29 maggio 2011.

archive.org

RM. Raffaelli, M. Paladini; H. Hanson; L. Kornstein; A. Agasan; S. Slavinski; D. Weiss; GJ. Fennelly; JT. Flynn, Child care-associated outbreak of Escherichia coli O157:H7 and hemolytic uremic syndrome., in Pediatr Infect Dis J, vol. 26, n. 10, ottobre 2007, pp. 951-3, DOI:10.1097/INF.0b013e31812571f6, PMID 17901803.
DD. Ferguson, J. Scheftel; A. Cronquist; K. Smith; A. Woo-Ming; E. Anderson; J. Knutsen; AK. De; K. Gershman, Temporally distinct Escherichia coli 0157 outbreaks associated with alfalfa sprouts linked to a common seed source--Colorado and Minnesota, 2003., in Epidemiol Infect, vol. 133, n. 3, giugno 2005, pp. 439-47, PMID 15962550.
IN. Okeke, O. Ojo; A. Lamikanra; JB. Kaper, Etiology of acute diarrhea in adults in southwestern Nigeria., in J Clin Microbiol, vol. 41, n. 10, ottobre 2003, pp. 4525-30, PMID 14532177.
Chu P, Hemphill RR, 222: Acquired hemolytic anemia, in Tintinalli JE, Kelen GD, Stapczynski JS (a cura di), Emergency Medicine: A Comprehensive Study Guide, 6th, New York, NY, McGraw-Hill, 2004, ISBN 0-07-138875-3.
JL. Moake, Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome., in Arch Pathol Lab Med, vol. 126, n. 11, novembre 2002, pp. 1430-3, DOI:10.1043/0003-9985(2002)1261430:TTPATH2.0.CO;2, PMID 12421153.
KC. Johnson-Henry, KA. Donato; G. Shen-Tu; M. Gordanpour; PM. Sherman, Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function., in Infect Immun, vol. 76, n. 4, aprile 2008, pp. 1340-8, DOI:10.1128/IAI.00778-07, PMID 18227169.
MJ. Medellin-Peña, H. Wang; R. Johnson; S. Anand; MW. Griffiths, Probiotics affect virulence-related gene expression in Escherichia coli O157:H7., in Appl Environ Microbiol, vol. 73, n. 13, luglio 2007, pp. 4259-67, DOI:10.1128/AEM.00159-07, PMID 17496132.
PM. Sherman, KC. Johnson-Henry; HP. Yeung; PS. Ngo; J. Goulet; TA. Tompkins, Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements., in Infect Immun, vol. 73, n. 8, agosto 2005, pp. 5183-8, DOI:10.1128/IAI.73.8.5183-5188.2005, PMID 16041036.
T. Asahara, K. Shimizu; K. Nomoto; T. Hamabata; A. Ozawa; Y. Takeda, Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7., in Infect Immun, vol. 72, n. 4, aprile 2004, pp. 2240-7, PMID 15039348.
T. Zhao, MP. Doyle; BG. Harmon; CA. Brown; PO. Mueller; AH. Parks, Reduction of carriage of enterohemorrhagic Escherichia coli O157:H7 in cattle by inoculation with probiotic bacteria., in J Clin Microbiol, vol. 36, n. 3, marzo 1998, pp. 641-7, PMID 9508288.

books.google.com

Larizza, p. 2181. Paolo Larizza, Trattato delle malattie del sangue, Piccin, 1991, ISBN 978-88-299-0854-7. URL consultato il 28 maggio 2011.
Lorini, Di Pietro e Romano, p. 281. R. Lorini, P. Di Pietro e C. Romano, Pediatria d'urgenza, Elsevier, 2005, ISBN 978-88-214-2638-4.
Carosi e Pauluzzi, p. 119. Giampiero Carosi e Sergio Pauluzzi, Malattie infettive, Piccin, 2007, ISBN 978-88-299-1844-7.
Eric Schlosser, Fast food nation. Il lato oscuro del cheeseburger, Il Saggiatore, p. 225, ISBN 978-88-565-0028-8. URL consultato il 29 maggio 2011.
Marriott e Gravani, p. 6. Norman G. Marriott e Robert B. Gravani, Sanificazione nell'industria alimentare, Springer, dicembre 2007, ISBN 978-88-470-0787-1.
Christopher D. Hillyer, Beth H. Shaz, James C. Zimring, Thomas C. Abshire, Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects, Elsevier, 17 giugno 2009, p. 635, ISBN 978-0-12-374432-6. URL consultato il 28 maggio 2011.
Gaetano Crepaldi e Aldo Baritussio, Trattato di medicina interna, Piccin, 2002, p. 3240, ISBN 978-88-299-1642-9. URL consultato il 28 maggio 2011.
Mario Raso, Trattato di anatomia patologica clinica, Piccin, 1986, p. 498, ISBN 978-88-299-0409-9.
Bartolozzi e Guglielmelli, p. 1048. Giorgio Bartolozzi e Maurizio Guglielmelli, Pediatria. Principi e pratica clinica. Con CD-ROM, Elsevier, 2008, ISBN 978-88-214-3033-6.

doi.org

dx.doi.org

RM. Raffaelli, M. Paladini; H. Hanson; L. Kornstein; A. Agasan; S. Slavinski; D. Weiss; GJ. Fennelly; JT. Flynn, Child care-associated outbreak of Escherichia coli O157:H7 and hemolytic uremic syndrome., in Pediatr Infect Dis J, vol. 26, n. 10, ottobre 2007, pp. 951-3, DOI:10.1097/INF.0b013e31812571f6, PMID 17901803.
DG. Matsell, CT. White, An outbreak of diarrhea-associated childhood hemolytic uremic syndrome: the Walkerton epidemic., in Kidney Int Suppl, n. 112, febbraio 2009, pp. S35-7, DOI:10.1038/ki.2008.628, PMID 19180130.
JA. Crump, AC. Sulka; AJ. Langer; C. Schaben; AS. Crielly; R. Gage; M. Baysinger; M. Moll; G. Withers; DM. Toney; SB. Hunter, An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm., in N Engl J Med, vol. 347, n. 8, agosto 2002, pp. 555-60, DOI:10.1056/NEJMoa020524, PMID 12192014.
C. Zoja, S. Buelli; M. Morigi, Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction., in Pediatr Nephrol, vol. 25, n. 11, novembre 2010, pp. 2231-40, DOI:10.1007/s00467-010-1522-1, PMID 20424866.
PI. Tarr, Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis., in Kidney Int Suppl, n. 112, febbraio 2009, pp. S29-32, DOI:10.1038/ki.2008.615, PMID 19180128.
J. Scheiring, SP. Andreoli; LB. Zimmerhackl, Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)., in Pediatr Nephrol, vol. 23, n. 10, ottobre 2008, pp. 1749-60, DOI:10.1007/s00467-008-0935-6, PMID 18704506.
A. Serna, EC. Boedeker, Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections., in Curr Opin Gastroenterol, vol. 24, n. 1, gennaio 2008, pp. 38-47, DOI:10.1097/MOG.0b013e3282f2dfb8, PMID 18043231.
JE. Sadler, JL. Moake; T. Miyata; JN. George, Recent advances in thrombotic thrombocytopenic purpura., in Hematology Am Soc Hematol Educ Program, 2004, pp. 407-23, DOI:10.1182/asheducation-2004.1.407, PMID 15561695.
O. Köse, LB. Zimmerhackl; T. Jungraithmayr; C. Mache; J. Nürnberger, New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab., in Semin Thromb Hemost, vol. 36, n. 6, settembre 2010, pp. 669-72, DOI:10.1055/s-0030-1262889, PMID 20865644.
AM. Waters, C. Licht, aHUS caused by complement dysregulation: new therapies on the horizon., in Pediatr Nephrol, vol. 26, n. 1, gennaio 2011, pp. 41-57, DOI:10.1007/s00467-010-1556-4, PMID 20556434.
LB. Zimmerhackl, J. Hofer; G. Cortina; W. Mark; R. Würzner; TC. Jungraithmayr; G. Khursigara; KO. Kliche; W. Radauer, Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome., in N Engl J Med, vol. 362, n. 18, maggio 2010, pp. 1746-8, DOI:10.1056/NEJMc1001060, PMID 20445192.
CJ. Mache, B. Acham-Roschitz; V. Frémeaux-Bacchi; M. Kirschfink; PF. Zipfel; S. Roedl; U. Vester; E. Ring, Complement inhibitor eculizumab in atypical hemolytic uremic syndrome., in Clin J Am Soc Nephrol, vol. 4, n. 8, agosto 2009, pp. 1312-6, DOI:10.2215/CJN.01090209, PMID 19556379.
JI. Shin, JS. Lee, More on eculizumab for congenital atypical hemolytic-uremic syndrome., in N Engl J Med, vol. 360, n. 20, maggio 2009, pp. 2142-3; author reply 2143, DOI:10.1056/NEJMc090453, PMID 19439754.
RA. Gruppo, RP. Rother, Eculizumab for congenital atypical hemolytic-uremic syndrome., in N Engl J Med, vol. 360, n. 5, gennaio 2009, pp. 544-6, DOI:10.1056/NEJMc0809959, PMID 19179329.
CS. Wong, S. Jelacic; RL. Habeeb; SL. Watkins; PI. Tarr, The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections., in N Engl J Med, vol. 342, n. 26, giugno 2000, pp. 1930-6, DOI:10.1056/NEJM200006293422601, PMID 10874060.
GZ. Panos, GI. Betsi; ME. Falagas, Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?, in Aliment Pharmacol Ther, vol. 24, n. 5, settembre 2006, pp. 731-42, DOI:10.1111/j.1365-2036.2006.03036.x, PMID 16918877.
M. Bitzan, F. Schaefer; D. Reymond, Treatment of typical (enteropathic) hemolytic uremic syndrome., in Semin Thromb Hemost, vol. 36, n. 6, settembre 2010, pp. 594-610, DOI:10.1055/s-0030-1262881, PMID 20865636.
MS. Palermo, RA. Exeni; GC. Fernández, Hemolytic uremic syndrome: pathogenesis and update of interventions., in Expert Rev Anti Infect Ther, vol. 7, n. 6, agosto 2009, pp. 697-707, DOI:10.1586/eri.09.49, PMID 19681698.
M. Michael, EJ. Elliott; GF. Ridley; EM. Hodson; JC. Craig, Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura., in Cochrane Database Syst Rev, n. 1, 2009, pp. CD003595, DOI:10.1002/14651858.CD003595.pub2, PMID 19160220.
PF. Zipfel, C. Skerka, Complement dysfunction in hemolytic uremic syndrome., in Curr Opin Rheumatol, vol. 18, n. 5, settembre 2006, pp. 548-55, DOI:10.1097/01.bor.0000240370.47336.ae, PMID 16896298.
JL. Moake, Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome., in Arch Pathol Lab Med, vol. 126, n. 11, novembre 2002, pp. 1430-3, DOI:10.1043/0003-9985(2002)1261430:TTPATH2.0.CO;2, PMID 12421153.
CM. Carey, M. Kostrzynska; S. Ojha; S. Thompson, The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7., in J Microbiol Methods, vol. 73, n. 2, maggio 2008, pp. 125-32, DOI:10.1016/j.mimet.2008.01.014, PMID 18328583.
KC. Johnson-Henry, KA. Donato; G. Shen-Tu; M. Gordanpour; PM. Sherman, Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function., in Infect Immun, vol. 76, n. 4, aprile 2008, pp. 1340-8, DOI:10.1128/IAI.00778-07, PMID 18227169.
N. Jandu, ZJ. Zeng; KC. Johnson-Henry; PM. Sherman, Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon-gamma-induced tyrosine phosphorylation of STAT-1., in Microbiology, vol. 155, Pt 2, febbraio 2009, pp. 531-40, DOI:10.1099/mic.0.021931-0, PMID 19202101.
MJ. Medellin-Peña, H. Wang; R. Johnson; S. Anand; MW. Griffiths, Probiotics affect virulence-related gene expression in Escherichia coli O157:H7., in Appl Environ Microbiol, vol. 73, n. 13, luglio 2007, pp. 4259-67, DOI:10.1128/AEM.00159-07, PMID 17496132.
PM. Sherman, KC. Johnson-Henry; HP. Yeung; PS. Ngo; J. Goulet; TA. Tompkins, Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements., in Infect Immun, vol. 73, n. 8, agosto 2005, pp. 5183-8, DOI:10.1128/IAI.73.8.5183-5188.2005, PMID 16041036.

iss.it

epicentro.iss.it

Sindrome emolitico-uremica, su epicentro.iss.it, Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute. URL consultato il 23 gennaio 2012.

medscape.com

emedicine.medscape.com

Medscape: Medscape Access, su emedicine.medscape.com. URL consultato il 29 maggio 2011.
Pediatric Hemolytic Uremic Syndrome
Medscape: Medscape Access, su emedicine.medscape.com. URL consultato il 29 maggio 2011.
Medscape: Medscape Access, su emedicine.medscape.com. URL consultato il 29 maggio 2011.

msdmanuals.com

Sindrome emolitico-uremica (SEU) - Disturbi del sangue, su Manuale MSD, versione per i pazienti. URL consultato il 13 gennaio 2021.

nih.gov

ncbi.nlm.nih.gov

Corrigan JJ, Boineau FG, Hemolytic-uremic syndrome, in Pediatr Rev, vol. 22, n. 11, novembre 2001, pp. 365–9, PMID 11691946.
Anagnou NP, Papanicolaou N, Fessas P, Recurrent attacks of hemolytic uremic syndrome, in Haematologia (Budap), vol. 24, n. 2, 1991, pp. 101–5, PMID 1816053.
(DE) Gasser C, Gautier E, Steck A, Siebenmann RE, Oechslin R, Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia, in Schweiz Med Wochenschr, vol. 85, n. 38-39, settembre 1955, pp. 905–9, PMID 13274004.
S. Razzaq, Hemolytic uremic syndrome: an emerging health risk., in Am Fam Physician, vol. 74, n. 6, settembre 2006, pp. 991-6, PMID 17002034.
RM. Raffaelli, M. Paladini; H. Hanson; L. Kornstein; A. Agasan; S. Slavinski; D. Weiss; GJ. Fennelly; JT. Flynn, Child care-associated outbreak of Escherichia coli O157:H7 and hemolytic uremic syndrome., in Pediatr Infect Dis J, vol. 26, n. 10, ottobre 2007, pp. 951-3, DOI:10.1097/INF.0b013e31812571f6, PMID 17901803.
DG. Matsell, CT. White, An outbreak of diarrhea-associated childhood hemolytic uremic syndrome: the Walkerton epidemic., in Kidney Int Suppl, n. 112, febbraio 2009, pp. S35-7, DOI:10.1038/ki.2008.628, PMID 19180130.
DD. Ferguson, J. Scheftel; A. Cronquist; K. Smith; A. Woo-Ming; E. Anderson; J. Knutsen; AK. De; K. Gershman, Temporally distinct Escherichia coli 0157 outbreaks associated with alfalfa sprouts linked to a common seed source--Colorado and Minnesota, 2003., in Epidemiol Infect, vol. 133, n. 3, giugno 2005, pp. 439-47, PMID 15962550.
P. Bidet, P. Mariani-Kurkdjian; F. Grimont; N. Brahimi; C. Courroux; P. Grimont; E. Bingen, Characterization of Escherichia coli O157 : H7 isolates causing haemolytic uraemic syndrome in France., in J Med Microbiol, vol. 54, Pt 1, gennaio 2005, pp. 71-5, PMID 15591258.
IN. Okeke, O. Ojo; A. Lamikanra; JB. Kaper, Etiology of acute diarrhea in adults in southwestern Nigeria., in J Clin Microbiol, vol. 41, n. 10, ottobre 2003, pp. 4525-30, PMID 14532177.
JA. Crump, AC. Sulka; AJ. Langer; C. Schaben; AS. Crielly; R. Gage; M. Baysinger; M. Moll; G. Withers; DM. Toney; SB. Hunter, An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm., in N Engl J Med, vol. 347, n. 8, agosto 2002, pp. 555-60, DOI:10.1056/NEJMoa020524, PMID 12192014.
P. Cunin, E. Tedjouka; Y. Germani; C. Ncharre; R. Bercion; J. Morvan; PM. Martin, An epidemic of bloody diarrhea: Escherichia coli O157 emerging in Cameroon?, in Emerg Infect Dis, vol. 5, n. 2, pp. 285-90, PMID 10221885.
SF. Altekruse, ML. Cohen; DL. Swerdlow, Emerging foodborne diseases., in Emerg Infect Dis, vol. 3, n. 3, pp. 285-93, PMID 9284372.
C. Zoja, S. Buelli; M. Morigi, Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction., in Pediatr Nephrol, vol. 25, n. 11, novembre 2010, pp. 2231-40, DOI:10.1007/s00467-010-1522-1, PMID 20424866.
PI. Tarr, Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis., in Kidney Int Suppl, n. 112, febbraio 2009, pp. S29-32, DOI:10.1038/ki.2008.615, PMID 19180128.
J. Scheiring, SP. Andreoli; LB. Zimmerhackl, Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)., in Pediatr Nephrol, vol. 23, n. 10, ottobre 2008, pp. 1749-60, DOI:10.1007/s00467-008-0935-6, PMID 18704506.
A. Serna, EC. Boedeker, Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections., in Curr Opin Gastroenterol, vol. 24, n. 1, gennaio 2008, pp. 38-47, DOI:10.1097/MOG.0b013e3282f2dfb8, PMID 18043231.
JE. Sadler, JL. Moake; T. Miyata; JN. George, Recent advances in thrombotic thrombocytopenic purpura., in Hematology Am Soc Hematol Educ Program, 2004, pp. 407-23, DOI:10.1182/asheducation-2004.1.407, PMID 15561695.
(EN) Stefanidis I, Helmchen U, Schmitt H, Maurin N, Sieberth HG., Coincidence of haemolytic uraemic syndrome and c-ANCA-associated rapidly progressive glomerulonephritis, in Oxford Journals - Nephrology Dialysis Transplantation, luglio 1998, PMID 9681736.
O. Köse, LB. Zimmerhackl; T. Jungraithmayr; C. Mache; J. Nürnberger, New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab., in Semin Thromb Hemost, vol. 36, n. 6, settembre 2010, pp. 669-72, DOI:10.1055/s-0030-1262889, PMID 20865644.
AM. Waters, C. Licht, aHUS caused by complement dysregulation: new therapies on the horizon., in Pediatr Nephrol, vol. 26, n. 1, gennaio 2011, pp. 41-57, DOI:10.1007/s00467-010-1556-4, PMID 20556434.
LB. Zimmerhackl, J. Hofer; G. Cortina; W. Mark; R. Würzner; TC. Jungraithmayr; G. Khursigara; KO. Kliche; W. Radauer, Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome., in N Engl J Med, vol. 362, n. 18, maggio 2010, pp. 1746-8, DOI:10.1056/NEJMc1001060, PMID 20445192.
CJ. Mache, B. Acham-Roschitz; V. Frémeaux-Bacchi; M. Kirschfink; PF. Zipfel; S. Roedl; U. Vester; E. Ring, Complement inhibitor eculizumab in atypical hemolytic uremic syndrome., in Clin J Am Soc Nephrol, vol. 4, n. 8, agosto 2009, pp. 1312-6, DOI:10.2215/CJN.01090209, PMID 19556379.
JI. Shin, JS. Lee, More on eculizumab for congenital atypical hemolytic-uremic syndrome., in N Engl J Med, vol. 360, n. 20, maggio 2009, pp. 2142-3; author reply 2143, DOI:10.1056/NEJMc090453, PMID 19439754.
RA. Gruppo, RP. Rother, Eculizumab for congenital atypical hemolytic-uremic syndrome., in N Engl J Med, vol. 360, n. 5, gennaio 2009, pp. 544-6, DOI:10.1056/NEJMc0809959, PMID 19179329.
CS. Wong, S. Jelacic; RL. Habeeb; SL. Watkins; PI. Tarr, The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections., in N Engl J Med, vol. 342, n. 26, giugno 2000, pp. 1930-6, DOI:10.1056/NEJM200006293422601, PMID 10874060.
GZ. Panos, GI. Betsi; ME. Falagas, Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?, in Aliment Pharmacol Ther, vol. 24, n. 5, settembre 2006, pp. 731-42, DOI:10.1111/j.1365-2036.2006.03036.x, PMID 16918877.
M. Bitzan, F. Schaefer; D. Reymond, Treatment of typical (enteropathic) hemolytic uremic syndrome., in Semin Thromb Hemost, vol. 36, n. 6, settembre 2010, pp. 594-610, DOI:10.1055/s-0030-1262881, PMID 20865636.
MS. Palermo, RA. Exeni; GC. Fernández, Hemolytic uremic syndrome: pathogenesis and update of interventions., in Expert Rev Anti Infect Ther, vol. 7, n. 6, agosto 2009, pp. 697-707, DOI:10.1586/eri.09.49, PMID 19681698.
M. Michael, EJ. Elliott; GF. Ridley; EM. Hodson; JC. Craig, Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura., in Cochrane Database Syst Rev, n. 1, 2009, pp. CD003595, DOI:10.1002/14651858.CD003595.pub2, PMID 19160220.
PF. Zipfel, C. Skerka, Complement dysfunction in hemolytic uremic syndrome., in Curr Opin Rheumatol, vol. 18, n. 5, settembre 2006, pp. 548-55, DOI:10.1097/01.bor.0000240370.47336.ae, PMID 16896298.
TC. Nguyen, B. Stegmayr; R. Busund; TE. Bunchman; JA. Carcillo, Plasma therapies in thrombotic syndromes., in Int J Artif Organs, vol. 28, n. 5, maggio 2005, pp. 459-65, PMID 15883960.
MB. Marques, CA. Mayfield; DP. Blackall, Thrombotic thrombocytopenic purpura: from platelet aggregates to plasma., in Am J Clin Pathol, 121 Suppl, giugno 2004, pp. S89-96, PMID 15298154.
JL. Moake, Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome., in Arch Pathol Lab Med, vol. 126, n. 11, novembre 2002, pp. 1430-3, DOI:10.1043/0003-9985(2002)1261430:TTPATH2.0.CO;2, PMID 12421153.
CM. Carey, M. Kostrzynska; S. Ojha; S. Thompson, The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7., in J Microbiol Methods, vol. 73, n. 2, maggio 2008, pp. 125-32, DOI:10.1016/j.mimet.2008.01.014, PMID 18328583.
KC. Johnson-Henry, KA. Donato; G. Shen-Tu; M. Gordanpour; PM. Sherman, Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function., in Infect Immun, vol. 76, n. 4, aprile 2008, pp. 1340-8, DOI:10.1128/IAI.00778-07, PMID 18227169.
N. Jandu, ZJ. Zeng; KC. Johnson-Henry; PM. Sherman, Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon-gamma-induced tyrosine phosphorylation of STAT-1., in Microbiology, vol. 155, Pt 2, febbraio 2009, pp. 531-40, DOI:10.1099/mic.0.021931-0, PMID 19202101.
Y. Kim, SH. Kim; KY. Whang; YJ. Kim; S. Oh, Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells., in J Microbiol Biotechnol, vol. 18, n. 7, luglio 2008, pp. 1278-85, PMID 18667857.
MJ. Medellin-Peña, H. Wang; R. Johnson; S. Anand; MW. Griffiths, Probiotics affect virulence-related gene expression in Escherichia coli O157:H7., in Appl Environ Microbiol, vol. 73, n. 13, luglio 2007, pp. 4259-67, DOI:10.1128/AEM.00159-07, PMID 17496132.
PM. Sherman, KC. Johnson-Henry; HP. Yeung; PS. Ngo; J. Goulet; TA. Tompkins, Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements., in Infect Immun, vol. 73, n. 8, agosto 2005, pp. 5183-8, DOI:10.1128/IAI.73.8.5183-5188.2005, PMID 16041036.
T. Asahara, K. Shimizu; K. Nomoto; T. Hamabata; A. Ozawa; Y. Takeda, Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7., in Infect Immun, vol. 72, n. 4, aprile 2004, pp. 2240-7, PMID 15039348.
T. Zhao, MP. Doyle; BG. Harmon; CA. Brown; PO. Mueller; AH. Parks, Reduction of carriage of enterohemorrhagic Escherichia coli O157:H7 in cattle by inoculation with probiotic bacteria., in J Clin Microbiol, vol. 36, n. 3, marzo 1998, pp. 641-7, PMID 9508288.

oadoi.org

DG. Matsell, CT. White, An outbreak of diarrhea-associated childhood hemolytic uremic syndrome: the Walkerton epidemic., in Kidney Int Suppl, n. 112, febbraio 2009, pp. S35-7, DOI:10.1038/ki.2008.628, PMID 19180130.
JA. Crump, AC. Sulka; AJ. Langer; C. Schaben; AS. Crielly; R. Gage; M. Baysinger; M. Moll; G. Withers; DM. Toney; SB. Hunter, An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm., in N Engl J Med, vol. 347, n. 8, agosto 2002, pp. 555-60, DOI:10.1056/NEJMoa020524, PMID 12192014.
C. Zoja, S. Buelli; M. Morigi, Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction., in Pediatr Nephrol, vol. 25, n. 11, novembre 2010, pp. 2231-40, DOI:10.1007/s00467-010-1522-1, PMID 20424866.
PI. Tarr, Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis., in Kidney Int Suppl, n. 112, febbraio 2009, pp. S29-32, DOI:10.1038/ki.2008.615, PMID 19180128.
J. Scheiring, SP. Andreoli; LB. Zimmerhackl, Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)., in Pediatr Nephrol, vol. 23, n. 10, ottobre 2008, pp. 1749-60, DOI:10.1007/s00467-008-0935-6, PMID 18704506.
A. Serna, EC. Boedeker, Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections., in Curr Opin Gastroenterol, vol. 24, n. 1, gennaio 2008, pp. 38-47, DOI:10.1097/MOG.0b013e3282f2dfb8, PMID 18043231.
JE. Sadler, JL. Moake; T. Miyata; JN. George, Recent advances in thrombotic thrombocytopenic purpura., in Hematology Am Soc Hematol Educ Program, 2004, pp. 407-23, DOI:10.1182/asheducation-2004.1.407, PMID 15561695.
O. Köse, LB. Zimmerhackl; T. Jungraithmayr; C. Mache; J. Nürnberger, New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab., in Semin Thromb Hemost, vol. 36, n. 6, settembre 2010, pp. 669-72, DOI:10.1055/s-0030-1262889, PMID 20865644.
AM. Waters, C. Licht, aHUS caused by complement dysregulation: new therapies on the horizon., in Pediatr Nephrol, vol. 26, n. 1, gennaio 2011, pp. 41-57, DOI:10.1007/s00467-010-1556-4, PMID 20556434.
LB. Zimmerhackl, J. Hofer; G. Cortina; W. Mark; R. Würzner; TC. Jungraithmayr; G. Khursigara; KO. Kliche; W. Radauer, Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome., in N Engl J Med, vol. 362, n. 18, maggio 2010, pp. 1746-8, DOI:10.1056/NEJMc1001060, PMID 20445192.
CJ. Mache, B. Acham-Roschitz; V. Frémeaux-Bacchi; M. Kirschfink; PF. Zipfel; S. Roedl; U. Vester; E. Ring, Complement inhibitor eculizumab in atypical hemolytic uremic syndrome., in Clin J Am Soc Nephrol, vol. 4, n. 8, agosto 2009, pp. 1312-6, DOI:10.2215/CJN.01090209, PMID 19556379.
JI. Shin, JS. Lee, More on eculizumab for congenital atypical hemolytic-uremic syndrome., in N Engl J Med, vol. 360, n. 20, maggio 2009, pp. 2142-3; author reply 2143, DOI:10.1056/NEJMc090453, PMID 19439754.
RA. Gruppo, RP. Rother, Eculizumab for congenital atypical hemolytic-uremic syndrome., in N Engl J Med, vol. 360, n. 5, gennaio 2009, pp. 544-6, DOI:10.1056/NEJMc0809959, PMID 19179329.
CS. Wong, S. Jelacic; RL. Habeeb; SL. Watkins; PI. Tarr, The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections., in N Engl J Med, vol. 342, n. 26, giugno 2000, pp. 1930-6, DOI:10.1056/NEJM200006293422601, PMID 10874060.
GZ. Panos, GI. Betsi; ME. Falagas, Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?, in Aliment Pharmacol Ther, vol. 24, n. 5, settembre 2006, pp. 731-42, DOI:10.1111/j.1365-2036.2006.03036.x, PMID 16918877.
M. Bitzan, F. Schaefer; D. Reymond, Treatment of typical (enteropathic) hemolytic uremic syndrome., in Semin Thromb Hemost, vol. 36, n. 6, settembre 2010, pp. 594-610, DOI:10.1055/s-0030-1262881, PMID 20865636.
MS. Palermo, RA. Exeni; GC. Fernández, Hemolytic uremic syndrome: pathogenesis and update of interventions., in Expert Rev Anti Infect Ther, vol. 7, n. 6, agosto 2009, pp. 697-707, DOI:10.1586/eri.09.49, PMID 19681698.
M. Michael, EJ. Elliott; GF. Ridley; EM. Hodson; JC. Craig, Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura., in Cochrane Database Syst Rev, n. 1, 2009, pp. CD003595, DOI:10.1002/14651858.CD003595.pub2, PMID 19160220.
PF. Zipfel, C. Skerka, Complement dysfunction in hemolytic uremic syndrome., in Curr Opin Rheumatol, vol. 18, n. 5, settembre 2006, pp. 548-55, DOI:10.1097/01.bor.0000240370.47336.ae, PMID 16896298.
CM. Carey, M. Kostrzynska; S. Ojha; S. Thompson, The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7., in J Microbiol Methods, vol. 73, n. 2, maggio 2008, pp. 125-32, DOI:10.1016/j.mimet.2008.01.014, PMID 18328583.
N. Jandu, ZJ. Zeng; KC. Johnson-Henry; PM. Sherman, Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon-gamma-induced tyrosine phosphorylation of STAT-1., in Microbiology, vol. 155, Pt 2, febbraio 2009, pp. 531-40, DOI:10.1099/mic.0.021931-0, PMID 19202101.

oxfordjournals.org

ndt.oxfordjournals.org

(EN) Stefanidis I, Helmchen U, Schmitt H, Maurin N, Sieberth HG., Coincidence of haemolytic uraemic syndrome and c-ANCA-associated rapidly progressive glomerulonephritis, in Oxford Journals - Nephrology Dialysis Transplantation, luglio 1998, PMID 9681736.

rcsb.org

(EN) RCSB PDB - 1R4P Structure Summary, su rcsb.org.

repubblica.it

Cetrioli contaminati, l'allarme dell'Ue Sei vittime in Germania, casi in altri sei Paesi - Repubblica.it, su repubblica.it. URL consultato il 29 maggio 2011.
Cetrioli contaminati, l'allarme dell'Ue Sei vittime in Germania, casi in altri sei Paesi- Repubblica.it, su repubblica.it. URL consultato il 28 maggio 2011.

state.il.us

idph.state.il.us

(EN) Escherichia coli O157:H7, su idph.state.il.us, Illinois Department of Public Health. URL consultato il 23 gennaio 2012.

web.archive.org

(EN) Outbreak of Shiga toxin-producing E. coli (STEC) in Germany (PDF), su ecdc.europa.eu, European Center for Disease Prevention and Control, 24 maggio 2011. URL consultato il 23 gennaio 2012 (archiviato dall'url originale il 18 marzo 2012).
TMNews - Salute/ Batterio E.Coli, in aumento i casi sospetti in Europa, su tmnews.it. URL consultato il 29 maggio 2011 (archiviato dall'url originale il 13 marzo 2014).
(DE) Neue Therapie gegen EHEC-Infektionen, su heute-gesund-leben.de. URL consultato il 23 gennaio 2012 (archiviato dall'url originale il 20 giugno 2012).

who.int

euro.who.int

WHO, EHEC outbreak: Update 30 (22 July 2011) This and previous updates are available at:[1]^{[collegamento interrotto]}